Position in NVAX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$141,253
+$28,344 QoQ
Shares Held
17,353
+3.3% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Scientech Research LLC holds $14,721,267 across 43 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
26,826 | $1,878,624 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
12,943 | $1,484,173 | |
| 3 | ABSI |
Absci Corp
|
124,434 | $1,442,190 | |
| 4 | NTLA |
Intellia Therapeutics, Inc.
|
72,533 | $1,227,258 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
3,378 | $1,130,920 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
15,341 | $843,755 | |
| 7 | DRTS |
Alpha Tau Medical Ltd.
|
45,752 | $575,560 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
14,456 | $563,928 |
All Filings in NVAX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $141,253 | 17,353 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $112,909 | 16,802 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $95,950 | 11,067 | Shares | Sole | 2025-11-14 | |
| 2024-06-30 | $217,296 | 17,164 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $193,852 | 40,555 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||